Elevated classical soluble HLA class I molecules in breast cancer patients are associated with favorable disease outcome
BACKGROUND: T cell recognition of human leukocyte antigen (HLA)-presented peptides plays a central role in immunosurveillance of malignant disease. Besides HLA molecules on cell surfaces, soluble HLA molecules (sHLA) are released in the blood and suggested to impact cellular immune responses. METHODS: Here, we investigate classical sHLA class I (HLA-A, -B, -C) molecules in pretreatment serum from 191 patients, either with invasive breast cancer (BC, n = 140) or with ductal carcinoma in situ (DCIS, n = 51), in relation to clinical parameters and survival with a follow-up time of up to 10 years. RESULTS: Classical sHLA class I serum levels were significantly elevated in patients with DCIS and invasive BC compared to a healthy control cohort. sHLA levels did not differ across molecular subtypes or menopausal status. Of note, higher sHLA class I levels at time of diagnosis were associated with prolonged overall survival independent of age and metastatic status. CONCLUSIONS: The findings of this study reveal first insights on classical sHLA class I molecules in BC patients suggesting an association of higher sHLA class I levels with favorable overall survival that warrants mechanistic investigation and identify sHLA as a potential candidate biomarker for further validation.
Authors
- Dominik Dannehl (ORCID: https://orcid.org/0000-0002-7653-8283)
- Sara Yvonne Brucker (ORCID: https://orcid.org/0000-0001-5162-1542)
- Andreas Daniel Hartkopf (ORCID: https://orcid.org/0000-0003-1227-1118)
- Jonas S. Heitmann (ORCID: https://orcid.org/0000-0002-7305-8620)
- Tobias Engler (ORCID: https://orcid.org/0000-0002-8063-2053)
- Christian Martin Tegeler (ORCID: https://orcid.org/0000-0001-6688-7351)
- Anna Seller (ORCID: https://orcid.org/0000-0003-0886-2177)
- André Koch
- Jonas Rieth
- Annika Nelde
- Juliane S. Walz
- Markus Hahn
Institutions
- German Cancer Research Center (DE)
- Universitätsklinikum Tübingen (DE)
- University Children's Hospital Tübingen (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1186/s12885-026-17386-0
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitätsklinikum Tübingen